|
 |
TelmisartanThis page contains recent news articles, when available, and an overview of Telmisartan but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.The treatment, called Micardis® (telmisartan) Tablets 80 mg, is now approved for reduction of the risk for heart attack, stroke or death from cardiovascular ... North American Press Syndicate Cipla in talks to supply drugs to Germany's BI - Dec 15, 2009 As per an industry official, the discussions are for two hypertension drugs — Telmisartan and a combination drug of Amlodipine and Telmisartan. ... Economic Times Boehringer Ingelheim begins ovarian cancer trial - Dec 23, 2009 Meanwhile, Boehringer-Ingelheim revealed last month that Micardis (telmisartan) - its treatment for the reduction of cardiovascular morbidity risk - was ... Zenopa A roundup of 2009's FDA-approved items - Dec 29, 2009 Twynsta (amlodipine and telmisartan) tablets: This combination drug treats hypertension; it's the marriage of Norvasc with Micardis in a single pill. ... Herald & Review Un nou medicament pentru reducerea riscului de deces cardiovascular - Dec 14, 2009 La scurt timp de la aprobarea acordata de Administratia Medicamentelor si Alimentelor din SUA (FDA), telmisartan (Micardis) a primit aprobarea Comisiei ... Eva Refuerzan castigos a laboratorios - Dec 10, 2009 La alemana Boehringer Ingelheim, a cargo aquà de Thorsten Poehl, sigue con buenas noticias, pues su medicamento Telmisartan para riesgo cardiovascular, ... El Economista.com.mx ASH Annual Meeting - 14 Nov 2009 Telmisartan plus amlodipine is superior to losartan plus amlodipine in reducing microalbuminuria in hypertensive patients with type 2 diabetes, ... Renal and Urology News FDA Expands Telmisartan Indications - Oct 19, 2009 WASHINGTON -- The FDA has expanded the indication for the antihypertension drug telmisartan (Micardis), ... MedPage Today FDA Approves TWYNSTA® (telmisartan plus amlodipine) a New Single Pill ... - Oct 19, 2009 Telmisartan is the only ARB with proven evidence to reduce CV death, myocardial infarction (heart attack) and stroke beyond the effect of BP reduction in a ... Reuters FDA Approves MICARDIS® (Telmisartan) As the First Treatment in its Class to ... - Oct 19, 2009 FDA Approves MICARDIS® (Telmisartan) As the First Treatment in its Class to Reduce the Risk of Heart Attack, Stroke, or Death from Cardiovascular Causes in ... Reuters CHMP Issues Positive Opinion for MICARDIS® (telmisartan) as the First ... - Oct 23, 2009 MICARDIS® (telmisartan) is set to be the ONLY treatment in its class with this indication, demonstrating proven cardiovascular (CV) protection in patients ... Reuters The Case for Dual Renin-Angiotensin System Inhibition - Nov 9, 2009 Ku et al 1 cite the findings of the Renal Outcomes With Telmisartan, Ramipril, or Both, in People at High Vascular Risk (ONTARGET) trial 2 in arguing ... Archives of Internal Medicine Sildenafil Ratiopharm Receives Positive Criticism From The EU Panel - Nov 12, 2009 Boehringer Ingelheim International GmbH, with Micardis (telmisartan) and Bayer Schering Pharma AG (developers of Levitra), with Pritor and Kinzalmo ... I-Newswire.com (press release) Clinical Trial: No - Nov 6, 2009 Methods: The authors analyzed data from the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET), as well as the ... Cardiosource FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and ... - Oct 19, 2009 The FDA also approved a New Drug Application (NDA) for the combination agent Twynsta® (telmisartan/amlodipine) Tablets for the treatment of hypertension ... Reuters ALLHAT Findings Revisited in the Context of Subsequent Analyses, Other Trials ... - Oct 26, 2009 The Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) report has raised further doubts of renoprotection with ... Archives of Internal Medicine Boehringer Ingelheim reveals FDA approval of Micardis - Oct 22, 2009 Boehringer Ingelheim has revealed that its treatment for patients at high risk of cardiovascular (CV) incidents - Micardis (telmisartan), has been approved ... Zenopa CHMP issues positive opinion for Boehringer Ingelheim's MICARDIS - Oct 24, 2009 Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on the approval of Micardis (telmisartan). ... Therapeutics Daily (press release) (registration) Boehringer Ingelheim drug Micardis receives positive recommendation - Oct 26, 2009 Medicines Evaluation Agency has issued a positive opinion for the approval of Micardis (telmisartan) for the reduction of cardiovascular (CV) morbidity. ... Zenopa Boehringer Ingelheim prize winner announced - Oct 30, 2009 This news comes after Boehringer Ingelheim received a positive opinion for the approval of Micardis (telmisartan) from the Committee for Medicinal Products ... Zenopa ACE inhibitors of benefit in ischemic heart disease patients with preserved LV ... - Oct 20, 2009 In TRANSCEND, the ARB telmisartan (Micardis, Boehringer Ingelheim) did not reduce the RR for individual components of an end point, but it did reduce the RR ... TheHeart.Org European regulators begin Tysabri review - Oct 26, 2009 Finally, the indications of three hypertension drugs - Boehringer Ingelheim's Micardis and Bayer Schering's Pritor and Kinzalmono (all telmisartan) - are ... Pharmafocus * The ONTARGET Trial results reviewed by the CHMP showed that Micardis® may ... - Oct 23, 2009 Telmisartan is a modern member of the Angiotensin II Receptor Blocker (ARB) class and was investigated in the most ambitious and far-reaching research ... PipelineReview.com (press release) EU Panel: Positive Opinion On Sildenafil Ratiopharm - Oct 23, 2009 Micardis (telmisartan), from Boehringer Ingelheim International GmbH, Pritor (telmisartan), from Bayer Schering Pharma AG, and Kinzalmono (telmisartan), ... EasyBourse.com Meminimalisir Efek Samping Obat Antihipertensi - Nov 10, 2009 Adapun obat saya konsumsi ada 3 macam Norvask 5 mg, Tenoretik 50 dan Telmisartan 5. Apa saran-saran Dokter agar keluhan kesehatan yang kami sebut di atas ... Republika Telmisartan – evidenzbasierte Schutzwirkung für Risikopatienten - Oct 22, 2009 Evidenzbasiert in Endpunktstudien dokumentiert sind sie nach Asmar bei den ACE-Hemmern nur für Ramipril und bei den AT1-Blockern nur für Telmisartan. ... IBTimes Deutschland GSK, 'í”„ë¦¬í† í”ŒëŸ¬ìŠ¤'출시 - Nov 12, 2009 ...환ìž?를 위해 보다 ê°•ë ¥í•´ì§„1,2, ARB와 ì?´ë‡¨ì œì?˜ ë³µí•©ì œì œì?¸ 'í”„ë¦¬í† í”ŒëŸ¬ìŠ¤ 80/25 ( 성분명: telmisartan/hydrochlorothiazide 80/25mg)를 지난 12ì?¼ 출시했다. ... 메디포뉴스 美 '미카르디스+노바스í?¬' ë³µí•©ì œ 승ì?¸ - Oct 19, 2009 ...미êµì—?ì„œ í•ê³ í˜ˆì••ì œ '미카르디스'(Micardis, telmisartan)와 '노바스í?¬'(Norvasc, amlodipine)ì?˜ ë³µí•©ì œì?¸ '트와ì?¸ìŠ¤íƒ€'(Twynsta) ì •ì œê°€ 승ì?¸ì?„ 받았다. ... 디지틀보사 InfarktusmegelÅ‘zés: új fegyver az arzenálban? - Oct 21, 2009 Az Egyesült Ã?llamok Élelmiszer és Gyógyszerhatósága bejelentette: új indikációban engedélyezték a Micardist (hatóanyag: telmisartan), a Boehringer Ingelheim ... Weborvos EXFORGEì?˜ 효능 효과 - Nov 2, 2009 ...하지만 ACEì–µì œì œë¥¼ 복용하지 못하는 환ìž?를 대ìƒ?으로 telmisartanì?„ 투여한 TRANSEND시험ì—?서는 6666명ì?„ telmisartanêµ°ê³¼ 위약 군으로 ìž„ì?˜ ë°°ì •í•œ 시험ì—?서는 위약 ... 코리아헬스로그 æ—¥ ì œë„¤ë¦ ì‹œìž¥ '외ìž?사 진출러시' - Nov 2, 2009 ...rabeprazole), 'ì—?비스타'(Evista, raloxifene), '미카르디스'(Micardis, telmisartan), 'ë ˆí?´ë?¼ìŠ¤íŠ¸'(Reclast, zoledronic acid)ì?˜ 만료가 ì˜ˆì •ë?¼ 있다. ... 디지틀보사 ベーリンガーインゲルãƒ?イムã€?アンジオテンシンＩＩå?—容体拮抗薬「ミカルディスã€?ã?§ ... - Oct 20, 2009 ...Ｔｅｌï½?ｉｓï½?ï½’ï½”ï½?ｎ，ｒï½?ï½?ｉï½?ｒｉｌ，ï½?ï½’ ｂï½?ｔｈ ｉｎ ï½?ï½?ｔｉｅｎｔｓ ï½?ï½” ｈｉｇｈ ｒｉｓｋ ｆï½?ï½’ ï½–ï½?ｓｃｕｌï½?ï½’ ｅｖｅｎｔｓ． ... 日本経済新聞 (プレスリリース) Study shows telmisartan reduces outcome of cardiovascular death - Sep 1, 2008 HAMILTON8 -- An international study led by Canadian researchers has found that telmisartan, a medication used to lower blood pressure, reduced the outcome ... Hindu Telmisartan (MICARDIS(R)) as Effective as Ramipril - Oct 24, 2008 New results from the landmark ONTARGET(R) Trial show that, in Asian patients at high risk of cardiovascular disease (CVD), telmisartan (MICARDIS(R)) 80mg is ... ANTARA Increasing telmisartan vs amlodipine dose in patients with hypertensio... - Apr 30, 2007 Fogari R et al. (2007) Effect of telmisartan–amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with ... Nature.com Newer Blood Pressure Drug No Better Than Placebo in Preventing Stroke - Aug 27, 2008 Telmisartan is an angiotensin II receptor blocker, which works by blocking the ... Sacco thinks that the longer someone takes telmisartan may increase its ... Washington Post Effect of Telmisartan–Amlodipine Combination at Different Doses on … - Jul 25, 2006 1 Department of Internal Medicine and Therapeutics, Clinica Medica II-IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy ... Nature.com A Multicenter, 14-Week Study of Telmisartan and Ramipril in Patients... - Mar 22, 2005 Correspondence: Dr. Yves Lacourcière, Director, Hypertension Research Unit, CHUL, Centre Hospitalier Universitaire de Quebec, 2705 boul Laurier S-135, ... Nature.com Effect of Telmisartan on Forearm Postischemic Hyperemia and Serum … - Apr 29, 2007 Correspondence: Dr. Akira Yamashina, Second Department of Internal Medicine, Tokyo Medical University, 6-7-1 Nishi-Shinjuku, Tokyo, 160-0023 Japan, ... Nature.com … and Magnetic Resonance Assessment of the Effect of Telmisartan … - Feb 3, 2005 Reductions in LVM index achieved with telmisartan were statistically superior to ... Conclusions: The superior LVM regression with telmisartan versus ... Nature.com Blood pressure drug Micardis cuts heart risk: study - Mar 31, 2008 The Boehringer Ingelheim drug Micardis, or telmisartan, is typically used in patients with heart ... Telmisartan is an angiotensin receptor blocker, or ARB. ... Reuters Blood pressure drug Telmisartan may help prevent stroke - Dec 13, 2007 Washington, Dec 13 : A new study has found that the drug Telmisartan has the potential of preventing stroke. A new study has found that the drug Telmisartan ... thecheers.org New blood-pressure drug has fewer side effects: study - Mar 31, 2008 Telmisartan rivals the commonly used ramipril in keeping heart attacks at bay, ... Telmisartan, an angiotensin II receptor, is better tolerated by patients, ... CBC.ca New Study Shows That Telmisartan Has Greater Renoprotective Potential... - Jun 19, 2007 AMADEO, one of the first studies to compare the protective potential of two angiotensin receptor blockers in hypertensive patients with diabetic nephropathy ... Medical News Today - Medical News Today (press release) Telmisartan is more effective than losartan in reducing proteinuria... - May 21, 2008 Correspondence: George Bakris, Department of medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois 60637-5415, USA. ... Nature.com Telmisartan Provides Superior, Powerful Blood Pressure Reduction From... - Jun 15, 2006 ..."Uncontrolled blood pressure can lead to organ damage which includes the heart, vascular system, kidneys and brain. Damage to these organs can cause ... DG News Science and Technology Reducing heart attack, stroke risks - Aug 16, 2007 Also, the 24-hour blood pressure was reduced with telmisartan alone and in combination ... Telmisartan was discovered and developed by Boehringer Ingelheim, ... Philippine Star … angiotensin receptor blocker telmisartan prevent morbid atheroscler... - May 21, 2008 ONTARGET has established the efficacy of the angiotensin receptor blocker (ARB) telmisartan to slow disease progression and delay or prevent morbid events ... Nature.com Hypertension; Telmisartan can reduce systolic BP and diastolic BP … - Feb 28, 2005 2005 FEB 28 - (NewsRx.com & NewsRx.net) -- A recent report described a multicenter, randomized, double-blind study of the efficacy and safety of telmisartan ... Pay-Per-View - Cardiovascular Week - Factiva, from Dow Jones Telmisartan (Systemic).(Drug overview) - May 1, 2006 Telmisartan ( tel-mi-SAR-tan) belongs to the class of medicines called angiotensin II receptor blockers (ARB). It is used to treat high blood pressure ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com How to stop diabetes wreaking lasting havoc - Jun 29, 2007 ...they were then able to show that injections of vitamin C could have the same effect in people, as did a blood-pressure-lowering drug called telmisartan. ... New Scientist Science and Technology Results of global telmisartan study released - May 29, 2008 ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET) results was recently presented at the 57th Annual Scientific ... Philippine Star Hypertension; Telmisartan can reduce systolic BP and diastolic BP … - Mar 4, 2005 2005 MAR 4 - (NewsRx.com & NewsRx.net) -- A recent report described a multicenter, randomized, double-blind study of the efficacy and safety of telmisartan ... Pay-Per-View - Drug Week - Factiva, from Dow Jones … 22nd Annual Scientific Meeting and Exposition: Amadeo: Telmisartan... - Jul 1, 2007 In a randomized, controlled trial, telmisartan demonstrated a greater ... Telmisartan is currently approved for the treatment of hypertension but is not ... Free with registration - Formulary - AccessMyLibrary.com … - News: New data show that telmisartan provides superior, powerful... - Jun 19, 2006 We hope you have enjoyed your visit so far. We notice that you're not currently an onmedica.com member. Would you like to join? Tell me more... ... OnMedica Telmisartan Superior to Ramipril in Preventing Morning Blood Pressure... - May 19, 2005 By Ed Susman. SAN FRANCISCO, CA -- May 19, 2005 -- The sometimes problematic early morning blood pressure surge is better prevented by the angiotensin ... DG News … (R) 80/25 (80mg telmisartan/25mg hydrochlorothiazide) Approved by... - Apr 14, 2008 Evidence for renal protective effects of telmisartan Further evidence of the exceptional ... In 2007, the AMADEO(R) trial showed that telmisartan achieved ... ots.at At a glance: Bayer blitz on hypertension drug telmisartan - Jan 19, 2006 What's this about? Bayer HealthCare has bought the rights to market the blood-pressure drug telmisartan in a number of European markets from GlaxoSmithKline ... PRWeek UK Telmisartan Improves Endothelial Function and Nitrate Tolerance in … - Sep 11, 2007 By Chris Berrie. VIENNA, AUSTRIA -- September 11, 2007 -- The angiotensin II blocker telmisartan improves endothelial function and prevents nitrate ... DG News Telmisartan May Be an Effective and Safe Alternative to Ramipril in … - Apr 7, 2008 By Mike Fillon. CHICAGO -- April 7, 2008 -- In patients with vascular disease or high-risk diabetes but without heart failure, telmisartan is an equally ... DG News Blood Pressure Drug Telmisartan Shows Powerful Activity Against... - Dec 17, 2007 ScienceDaily (Dec. 17, 2007) — Telmisartan, a drug widely used to help control blood pressure, may have uniquely potent activity in preventing stroke, ... sciencedaily.com Bayer HealthCare purchases Pritor business from GlaxoSmithKline - Jan 3, 2006 Under that agreement BHC promotes telmisartan under the brand name ... Telmisartan was discovered and developed by Boehringer Ingelheim who markets the ... webwire.com Hypertension; Telmisartan was effective for reducing morning home... - Feb 14, 2005 2005 FEB 14 - (NewsRx.com & NewsRx.net) -- A recent report describes the practical efficacy of telmisartan for decreasing morning home blood pressure and ... Pay-Per-View - Hematology Week - Factiva, from Dow Jones Telmisartan Fails to Protect Poststroke Patients Against Second Event... - May 20, 2008 By Ed Susman. NICE, France -- May 20, 2008 -- The angiotensin-receptor blocker telmisartan, when administered immediately after a stroke, did not provide ... DG News Hypertension; Telmisartan was effective for reducing morning home... - Feb 20, 2005 2005 FEB 20 - (NewsRx.com & NewsRx.net) -- A recent report describes the practical efficacy of telmisartan for decreasing morning home blood pressure and ... Pay-Per-View - Heart Disease Weekly - Factiva, from Dow Jones Telmisartan Reduces Proteinuria More Than Losartan: Presented at ASH - May 28, 2007 By Jill Stein. CHICAGO, IL -- May 28, 2007 -- Telmisartan is associated with a larger reduction in proteinuria than losartan in hypertensive patients with ... DG News Research backs telmisartan use - Sep 5, 2008 The angiotensin receptor blocker telmisartan can reduce the risk of cardiovascular death in high-risk patients who are intolerant to ACE inhibitors, ... Healthcare Republic - Healthcare Republic Potential Metabolic Effects of Micardis (Telmisartan) - Sep 13, 2005 Micardis has a beneficial effect on insulin resistance, blood sugars, and blood lipids, independent of its effect on the blood pressure. ... Diabetes In Control Telmisartan-Hydrochlorothiazide Outperforms Valsartan- … - May 29, 2007 By Jill Stein. CHICAGO, IL -- May 29, 2007 -- Telmisartan-hydrochlorothiazide 80/25 mg lowers systolic and diastolic blood pressure to a greater extent than ... DG News ONgoing Telmisartan Alone and in Combination With Ramipril Global … - May 19, 2008 Description: The goal of this trial was to determine whether the angiotensin-receptor blocker (ARB) telmisartan was noninferior to the ... Medscape Diabetes Therapy; Telmisartan lowers blood pressure and increases … - Feb 8, 2005 According to recent research from New Zealand, "In theory, a drug that inhibits the renin-angiotensin system in order to lower blood pressure and acts as a ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Bayer Healthcare to market telmisartan in Europe.(acquires business... - Jan 9, 2006 Leverkusen, Germany-based Bayer Healthcare, part of Bayer AG, says it has purchased the European business for Boehringer Ingelheim's blood pressure ... $4.95 - Pharma Marketletter - ECNext MORE THAN HALF OF HYPERTENSIVE PATIENTS REMAIN … - Jun 18, 2007 The mean morning ABP was significantly reduced by telmisartan alone and in combination ... These trials investigate the effects of telmisartan in providing ... Free with registration - AsiaPulse News - AccessMyLibrary.com Study shows telmisartan reduces outcome of cardiovascular death - Sep 6, 2008 New technique could eliminate inherited mitochondrial disease — [26 Aug 2009] — Researchers have developed an experimental technique with the potential to ... Science Centric Diabetes Therapy; Telmisartan lowers blood pressure and increases … - Feb 12, 2005 According to recent research from New Zealand, "In theory, a drug that inhibits the renin-angiotensin system in order to lower blood pressure and acts as a ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones … Control Has No Effect on Telmisartan-Related Improvements in... - Jun 25, 2007 By Jill Stein. CHICAGO, IL -- June 25, 2007 -- Chronic telmisartan treatment may slow the progression of renal disease in patients with type 2 diabetes and ... DG News Pritor® And Kinzalmono® As Protective As Current Gold Standard … - Apr 5, 2008 1) Telmisartan, marketed by Bayer under the brand names Pritor® and ... "The ONTARGET® Trial shows that telmisartan is a well-tolerated treatment in ... Medical News Today - Medical News Today (press release) University of Queensland; Telmisartan lowers blood pressure and … - Feb 9, 2005 According to recent research from New Zealand, "In theory, a drug that inhibits the renin-angiotensin system in order to lower blood pressure and acts as a ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones The Differential Effects of Angiotensin II Type 1 Receptor Blockers... - Jul 21, 2006 Conclusions: The dual ARB/PPAR agonist telmisartan achieved more microalbuminuria reduction than an ARB with no PPAR agonistic action, possibly through ... Nature.com TRANSCEND: Telmisartan may be potential treatment for high-risk … - Oct 25, 2008 Patients with vascular disease or high-risk diabetes who are unable to tolerate ACE inhibitors may have reduced cardiovascular death, myocardial infarction ... Endocrine Today Re-examining RAS-blocking treatment regimens for abrogating … - Sep 11, 2008 ONTARGET investigators (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358: 1547–1559 | Article | PubMed ... Nature.com Renal Outcomes With Telmisartan, Ramipril, or Both, in People at High... - Sep 15, 2008 Author(s): Mann JF, Schmieder RE, McQueen M, et al., on behalf of the ONTARGET Investigators. Study Question: What are the renal effects of ramipril, ... Cardiosource Telmisartan Plus Amlodipine Produces Greater Blood Pressure … - Jun 20, 2008 By Betty S. Riggs. BERLIN -- June 20, 2008 -- Combinations of various doses of telmisartan and amlodipine produced greater blood pressure (BP) reductions ... DG News PRoFESS® results announced at XVII European Stroke Conference - May 16, 2008 Initiation of blood pressure lowering with telmisartan after a stroke, ... Rate of new diabetes mellitus (125 in the telmisartan group and 151 in the ... webwire.com … published: Perseverance may pay with telmisartan in recurrent... - Aug 28, 2008 By Eleanor McDermid. MedWire News: Telmisartan treatment does not confer an overall reduction in recurrent stroke risk relative to placebo over a 2.5-year ... Medwire (subscription) Telmisartan Improves Night-Time Blood Pressure Control: Presented at ... - Jun 23, 2008 By Betty S. Riggs. BERLIN -- June 23, 2008 -- Telmisartan plus hydrochlorothiazide (HCTZ), as needed, has been shown to increase night-time control of blood ... DG News ARB equals ACE inhibitor in diabetic nephropathy.(Nephrology)( … - Jan 1, 2005 MUNICH -- The angiotensin receptor blocker telmisartan offered ... "From previous studies, we know telmisartan has a superior safety profile to [the ACE ... Pay-Per-View - Internal Medicine News - Factiva, from Dow Jones … Data Presented on Micardis(R) (Telmisartan) Tablets in Hypertensive... - Jun 18, 2007 New Data Presented on Micardis(R) (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Antiplatelets, Telmisartan Have No Effect on Disability Due to... - Aug 29, 2008 NEW YORK -- August 29, 2008 -- Disability due to recurrent stroke and cognitive decline in patients with ischaemic stroke was not different between 2 ... DG News … Levels Correlate With the Blood Pressure Response to Telmisartan... - Dec 19, 2006 After a 4-week drug-free period, telmisartan 20–40 mg was administered ... Telmisartan significantly decreased the 24-h ABP by 12 11 mm Hg systolic (P ... Nature.com … Dose Combinations of Telmisartan and Hydrochlorothiazide Produce … - Jun 23, 2008 By Betty S. Riggs. BERLIN -- June 23, 2008 -- Long-term therapy with a fixed dose combination of telmisartan 80 mg and hydrochlorothiazide (HCTZ) 25 mg ... DG News Asiaone - S'pore firm offers - Sep 15, 2008 The study has shown that telmisartan can be used as a substitute drug for ... Telmisartan has traditionally been used only to lower high blood pressure. ... AsiaOne High-Normal Glucose Boosts Heart Failure Risk - Mar 7, 2007 The cohort included 25620 patients enrolled in ONTARGET (Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial), ... MedPage Today New antihypertensive PritorPlus® 80/25 and Kinzalkomb® 80/25 … - Apr 21, 2008 The superiority of the fixed dose combination, 80 mg telmisartan/25 mg hydrochlorothiazide (T80/H25), versus 80 mg telmisartan/12.5 mg hydrochlorothiazide ... webwire.com … New Powerful Antihypertensive MicardisPlus(R) 80/25 (80mg telmisart... - Apr 14, 2008 New Powerful Antihypertensive MicardisPlus(R) 80/25 (80mg telmisartan/25mg hydrochlorothiazide) Approved by EU Commission. from PR Newswire Europe. Pay-Per-View - PR Newswire Europe - HighBeam Research Telmisartan failed to improve cardiac event rates.(Metabolic Disorders... - Oct 1, 2008 Telmisartan failed to improve cardiac event rates.(Metabolic Disorders)(Brief article) ... find Family Practice News articles. Pay-Per-View - Family Practice News - HighBeam Research … : Landmark Trial ONTARGET(R) Proves Telmisartan is as Protective as... - Mar 31, 2008 Landmark Trial ONTARGET(R) Proves Telmisartan is as Protective as Ramipril and Better Tolerated in a Broad High-Risk Cardiovascular Population. Pay-Per-View - PR Newswire Europe - HighBeam Research MicardisPlus® in older patients with systolic hypertension, study... - May 16, 2005 Telmisartan was discovered and developed by Boehringer Ingelheim, Germany. Boehringer Ingelheim markets telmisartan under the trademark Micardis® in 84 ... Medical News Today - Medical News Today (press release) Angiotensin II Receptor Blockers Downsize Adipocytes in Spontaneously... - May 21, 2006 Conclusions: Although both valsartan and telmisartan downsized adipocytes, adipocyte downsizing was significantly greater with telmisartan compared to ... Nature.com MicardisPlus® in older patients with systolic hypertension, study... - May 20, 2005 Telmisartan was discovered and developed by Boehringer Ingelheim, Germany. Boehringer Ingelheim markets telmisartan under the trademark Micardis® in 84 ... i-newswire.com ARBs versus ACEIs for High-Risk Vascular Patients - Jun 20, 2008 Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events. ... The combination of telmisartan and ramipril offered no advantage over ... Medscape The value of current interventions for obesity - Nov 23, 2006 The Telmisartan Reduction of IntraMyocellular fat (TRIM) study has been ... The study has randomized 120 patients to high-dose telmisartan (80–160 mg per ... Nature.com Jantungan? Lindungi dengan Telmisartan - Apr 9, 2008 TELMISARTAN, obat antihipertensi golongan angiotensin II Receptor Blocker (ARB) moderen, memberi perlindungan setara dengan Ramipril yang merupakan standar ... KOMPAS.com Press Release: TRANSCEND(TM) Trial Results Presented at European … - Aug 31, 2008 Landmark ARB trial investigated Micardis(R) (telmisartan) against placebo in reducing the composite endpoint of cardiovascular death, myocardial infarction, ... Pay-Per-View - PR Newswire - HighBeam Research New drug reduces risk of heart attack, strokes - Sep 3, 2008 The study on the drug, telmisartan, was led by Salim Yusuf and Koon Teo, ... “The remarkable tolerability of telmisartan is emphasised by the fact that ... Nation, Pakistan - The Nation, Pakistan Ontarget with high-risk cardiovascular patients - Apr 11, 2008 Ontarget results showed that telmisartan is just as good as ramipril but the former is ... Telmisartan and ramipril were originally used for the control of ... Inquirer.net Diabetes Therapy; Researchers detail new studies and findings in the ... - Apr 12, 2005 Study 3: Telmisartan provided greater improvement in plasma lipids than did eprosartan. ... Seated trough DBP was also reduced by telmisartan (p<0.01) and ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Telmisartan-ë‘? 마리 새를 한번ì—? 잡는다 - Jan 31, 2006 ...ê³ í˜ˆì••ê³¼ ì œ2형 당뇨병ì?€ 성ì?¸ì—?ì„œ í?”í•œ 질환으로 ì œ2형 당뇨병 환ìž?ì?˜ 60%ì—?ì„œ ê³ í˜ˆì•• ì?´ ë?™ë°˜ë?˜ì–´ 있다. Renin-angiotensin system(RAS)를 ì–µì œí•˜ëŠ” 치료는 ê³ í˜ˆì••ê³¼ ... 메디í?¬ë‰´ìŠ¤ University of Medicine & Dentistry of New; Researchers detail new... - Apr 13, 2005 Study 3: Telmisartan provided greater improvement in plasma lipids than did eprosartan. ... Seated trough DBP was also reduced by telmisartan (p<0.01) and ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Diabetes Therapy; Studies advance knowledge in diabetes therapy … - Jul 11, 2005 Study 3: Telmisartan provided greater improvement in plasma lipids than did eprosartan. ... Seated trough DBP was also reduced by telmisartan (p<0.01) and ... Pay-Per-View - Clinical Trials Week - Factiva, from Dow Jones Diabetes Therapy; Researchers detail new studies and findings in the ... - Apr 16, 2005 Study 3: Telmisartan provided greater improvement in plasma lipids than did eprosartan. ... Seated trough DBP was also reduced by telmisartan (p<0.01) and ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Blood Pressure Drug Protects Against Stroke - Dec 28, 2007 Telmisartan part of a class of commonly used antihypertensive drugs called angiotensin ... The rats also got either no medication, telmisartan alone, ... Ivanhoe Broadcast News New blood pressure medication has fewer side effects: global study - Feb 4, 2008 The study found a new drug telmisartan is as effective as the popular drug ... An alternate therapy, telmisartan, which is an angiotensin II receptor ... innovations report - Innovations-Report Dual RAAS inhibition reduces mortality in HD CHF. - Jun 16, 2005 ..."Our study showed that when added to conventional heart-failure therapy, telmisartan, at a dose of 80 mg a day, significantly reduced morbidity and ... Medscape ì œ2형 당뇨병ì?„ ë?™ë°˜í•œ ê³ í˜ˆì•• 환ìž?ì—?ì„œ telmisartanì?˜ í˜ˆë‹¹ì¡°ì ˆ 효과 - Jan 31, 2006 Diabeties careì?˜ 최근 연구ì—?ì„œ, Pershadsingh와 Kurtz는 angiotensin II type 1 receptor blockerì?¸ telmisartanì?´ ë‚´ë‹¹ëŠ¥ìž¥ì• í™˜ìž?ì—?ì„œ ì?¸ìŠ?린 ì €í•ì„±ê³¼ 중성지방ì?„ ... 메디í?¬ë‰´ìŠ¤ Cipla signs global supply deal with Boehringer - Dec 29, 2005 Telmisartan is a hypertensive drug on which Boehringer is very aggressive in ... If Boehringer uses the same franchise as Telmisartan for its combination, ... Rediff New drug to help hypertensives - Apr 3, 2008 A promising new drug 'Telmisartan', has emerged as a potent help to the growing number of ... The performance of Telmisartan has been on par with Ramipril, ... Hindu Business Line Una nueva opción terapéutica, telmisartan, reduce significativamente... - Apr 3, 2008 Madrid, 3 de abril de 2008 - Las enfermedades cardiovasculares son responsables de la tercera parte de todas las muertes en el mundo (cada año fallecen 17 ... acceso.com Waspadai_Komplikasi_Akibat_Hipertensi - Media Hidup Sehat - Apr 23, 2008 Baru-baru ini sebuah hasil penelitian tentang efektivitas salah satu jenis obat golongan ARB, yakni telmisartan, dirilis. Penelitian bernama studi Ontarget ... Media Indonesia ê³ í˜ˆì•• 약물, í‘œì ?장기 ì†?ìƒ? 보호ì—? ì´›ì ?â…¢ - Mar 18, 2008 PROTECTIONì?€ Telmisartanì?˜ í‘œì ?장기ì?˜ 보호효과를 조사한 ìž„ìƒ?연구를 ... ì €ëŠ” ì?´ì¤‘ ì—?ì„œ Telmisartanì?˜ ì‹ ìž¥ë³´í˜¸íš¨ê³¼ì™€ ê´€ë ¨ë?œ ìž„ìƒ?연구를 ë§?씀드리ë?„ë¡? í•˜ê² ìŠµë‹ˆë‹¤. ... 메디í?¬ë‰´ìŠ¤ Hipertensão - Estudo comprova eficácia de medicamento com menos … - Apr 1, 2008 Com o `Telmisartan`, medicamento já usado no tratamento da hipertensão mas só agora comprovado em estudo, os doentes de alto risco cardiovascular passam a ... RTP - RTP Hochrisiko-Patienten: Telmisartan bietet neben Blutdrucksenkung auch ... - Oct 16, 2006 Um Hypertoniker wirksam vor kardiovaskulären Ereignissen zu schützen, ist einerseits die effektive Blutdrucksenkung wichtig. Zum anderen haben manche ... journalmed.de … .-ONTARGET demuestra la superioridad de telmisartan sobre los IECA ... - Apr 1, 2008 CHICAGO, 1 (del enviado especial de EUROPA PRESS en Illinois, Javier Leo) El tratamiento para la hipertensión telmisartan, comercializado como 'Pritor' y ... ecodiario Bayer/Boehringer: Telmisartan so wirksam wie Standardtherapie - Mar 31, 2008 DÃœSSELDORF (Dow Jones)--Der Wirkstoff "Telmisartan" bietet Herz-Kreislauf-Hochrisikopatienten den gleichen Schutz vor einem kardiovaskulären Ereignis wie ... Euro am Sonntag تلميزرتان Telmisartan يتÙ?وق على لوزارتان Losartan Ù?ÙŠ Øماية الكلى من … - Oct 7, 2007 إن العلاج المألوÙ? للمرضى المصابين بداء السكري Ù„Øماية كليتهم من تأثير المرض والوقاية ... الرياض Telmisartan nei pazienti a rischio: lo studio TRANSCEND - Sep 3, 2008 Il telmisartan non ha ridotto l'end-point primario, rispetto al placebo, in pazienti ad alto rischio cardiovascolare. Nello studio TRANSCEND 5926 pazienti ... Pillole.org Telmisartan, antihipertensivo que ha demostrado reducir la … - Oct 28, 2008 Madrid, 28 de octubre de 2008. – La Fundación Fernández-Cruz celebra su XXVII Lección Memorial, bajo el tÃtulo “Progresos y Novedades de la Enfermedad ... acceso.com Telmisartan reduce el riesgo de muerte cardiovascular, infarto de … - Oct 9, 2008 Bilbao, 9 de octubre de 2008. Los resultados del estudio TRANSCEND®* demuestran que telmisartan reduce en un 13% el riesgo de muerte cardiovascular, ... acceso.com Telmisartan: Neben RR-Senkung auch Reduktion des kardiovaskulären … - Dec 22, 2006 Der AT1-Blocker Telmisartan beeinflusst auch den Lipid- und Fettstoffwechsel, wie aktuelle Studiendaten zeigen. Damit besitzt Telmisartan das Potenzial für ... journalmed.de Diabetes Therapy; Researchers report details of new studies and... - Apr 18, 2005 Study 3: An angiotensin II AT1 receptor antagonist, telmisartan augments glucose ... We thus examined the effect of telmisartan on insulin action using ... Pay-Per-View - Proteomics Weekly - Factiva, from Dow Jones ä¸å¤®æ—¥å ±ç¶²è·¯å ±-臺ç?£è?šç„¦ - Sep 9, 2008 ...內的四å??國家ã€?五百ä¹?百二å??å…ä½?的心血管高å?±éšªç—…人，çµ?果顯示，無法å¿?å?—ACEI副作用 的高å?±éšªæ‚£è€…，並ä¸?æœƒå› ç‚ºæ”¹ç”¨ARB製劑telmisartanè€Œå¢žåŠ å¿ƒè¡€ç®¡å’Œè…¦ä¸é¢¨çš„å?±éšªã€‚ ... ä¸å¤®æ—¥å ± TRANSCEND-Studie: Telmisartan reduziert kardiovaskuläre Ereignisse … - Oct 14, 2008 Kardiovaskuläre Risikopatienten, die eine bestmögliche Basistherapie erhalten, profitieren von einer zusätzlichen Behandlung mit dem AT1-Blocker Telmisartan ... journalmed.de |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |